On Tuesday, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) opened lower -3.77% from the last session, before settling in for the closing price of $24.42. Price fluctuations for AMPH have ranged from $22.74 to $53.96 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 18.07%. Company’s average yearly earnings per share was noted -18.84% at the time writing. With a float of $35.19 million, this company’s outstanding shares have now reached $47.62 million.
Let’s determine the extent of company efficiency that accounts for 2028 employees. In terms of profitability, gross margin is 50.4%, operating margin of 28.14%, and the pretax margin is 25.99%.
Amphastar Pharmaceuticals Inc (AMPH) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Amphastar Pharmaceuticals Inc is 26.15%, while institutional ownership is 74.99%. The most recent insider transaction that took place on Apr 01 ’25, was worth 14,190. In this transaction Director of this company sold 500 shares at a rate of $28.38, taking the stock ownership to the 73,909 shares. Before that another transaction happened on Apr 01 ’25, when Company’s Director proposed sale 500 for $28.86, making the entire transaction worth $14,430.
Amphastar Pharmaceuticals Inc (AMPH) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -18.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.03% during the next five years compared to 25.59% growth over the previous five years of trading.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Trading Performance Indicators
Check out the current performance indicators for Amphastar Pharmaceuticals Inc (AMPH). In the past quarter, the stock posted a quick ratio of 2.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.53. Likewise, its price to free cash flow for the trailing twelve months is 6.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.06, a number that is poised to hit 0.67 in the next quarter and is forecasted to reach 3.70 in one year’s time.
Technical Analysis of Amphastar Pharmaceuticals Inc (AMPH)
Looking closely at Amphastar Pharmaceuticals Inc (NASDAQ: AMPH), its last 5-days average volume was 0.73 million, which is a jump from its year-to-date volume of 0.62 million. As of the previous 9 days, the stock’s Stochastic %D was 22.10%. Additionally, its Average True Range was 1.25.
During the past 100 days, Amphastar Pharmaceuticals Inc’s (AMPH) raw stochastic average was set at 3.21%, which indicates a significant decrease from 11.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.91% in the past 14 days, which was higher than the 38.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.70, while its 200-day Moving Average is $39.85. However, in the short run, Amphastar Pharmaceuticals Inc’s stock first resistance to watch stands at $24.48. Second resistance stands at $25.47. The third major resistance level sits at $26.01. If the price goes on to break the first support level at $22.95, it is likely to go to the next support level at $22.41. Now, if the price goes above the second support level, the third support stands at $21.42.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Key Stats
There are currently 47,650K shares outstanding in the company with a market cap of 1.12 billion. Presently, the company’s annual sales total 731,970 K according to its annual income of 159,520 K. Last quarter, the company’s sales amounted to 186,520 K and its income totaled 37,960 K.
